The current book includes information regarding the fabrication study of Ivabradine Hydrochloride is a newly approved medicine used for symptomatic management of stable angina pectoris First specific heart rate lowering agent. It is having superior anti angina and anti-ischemic activity. It is also safe and efficient to control heart rate in clinical conditions. Ivabridine shows 40% bioavailability due to first pass metabolism. Therefore avoiding first pass metabolism buccal tablet is suitable dosage form designed and studied. This newer attempt may improve patient compliance which most vital concern these days. It may also lead to ease of drug administration and rapid and extensive drug absorption. This book will give brief outline regarding management of angina pectoris through some novel drug delivery options. It will give basic idea to all research students of UG and PG belongs to pharmaceutical science background.